Charles Kunsch
Director/Board Member at CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glenn Larsen | M | 70 |
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | 10 years |
| Harvey J. Berger | M | 74 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Robert Copeland | M | - |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | 7 years |
| Ben Wolozin | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | 10 years |
| Zaven Kaprielian | M | - |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | - |
| Adam Houghton | M | - |
AbbVie Ventures LLC
 AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois.
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | 3 years |
| Bruce Shook | M | 65 |
Penn State Research Foundation
 Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | - |
| Nagesh Mahanthappa | M | 59 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Shakti Narayan | M | - |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | 5 years |
| John Gustofson | M | - |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois.
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | 8 years |
| Thomas Shepherd | M | - | - | |
| Stuart Schreiber | M | - |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Thomas Cahill | M | 37 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Lucio Iannone | M | 41 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Maciej Wroblewski | M | - | 3 years | |
| Pawel Jerzy Holstinghausen-Holsten | M | 52 | 6 years | |
| Michal Jerzy Walczak | M | 39 | 5 years | |
| Chuan He | M | - |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | 7 years |
| Maria Sagan | F | - | - | |
| Damian Crowther | M | - |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | - |
| Jasmina Marjanovic | F | - |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | 3 years |
| Christian Schubert | M | - |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | 2 years |
| Jonathan Lanfear | M | 55 |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| Mary E. Good | F | 60 |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | - |
| Howard Y. Chang | M | - |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | 7 years |
| Krzysztof Samotij | M | 72 | 4 years | |
| Barbara Dalton | M | 69 |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | - |
| Amir Nashat | M | 51 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | - |
| Paul J. Schmitt | M | 73 |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | - |
| Brenda D. Gavin | M | 76 |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | 21 years |
| Jason Rhodes | M | 54 |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | 7 years |
| Catherine D. Strader | M | 70 |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | - |
| Bruce Booth | M | 49 |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | - |
| Jonathan Behr | M | - |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | - |
| Tim Edwards | M | - |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | - |
| Larry Lasky | M | 73 |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | - |
| Pamela Esposito | M | 50 |
Accent Therapeutics, Inc.
Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | - |
| Joel C. Barrish | M | - |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | 3 years |
| Robert Florczykowski | M | - | 2 years | |
| Bob Carpenter | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| David R. Grenon | M | 84 |
Massachusetts Biomedical Initiatives
| - |
| Duane Burnett | M | - |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | - |
| Danjuma Quarless | M | - |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Russell Medford | M | 69 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 16 years |
| Charles Deignan | M | 59 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 years |
| Mark P. Colonnese | M | 68 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 years |
| Bijan Khosrowshahi | M | 62 |
Drexel University
| 7 years |
| Val de Vassal | M | - |
Drexel University
| 10 years |
| Mitchell Glass | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 5 years |
| Dan Walsh | M | - |
Drexel University
| 5 years |
| David Paul Wilson | M | 69 |
Drexel University
| 2 years |
| Chris Harms | M | - |
Drexel University
| 2 years |
| Luba Greenwood | F | 45 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | 3 years |
| Robert Scott | M | 70 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 years |
| Rick Balonis | M | - |
Drexel University
| 5 years |
| Eugene March | M | - |
Drexel University
| 4 years |
| Shu Kwan Cheng | M | 59 |
Drexel University
| 4 years |
| Stephen J. Woerner | M | 56 |
Drexel University
| 4 years |
| Mark McAdoo | M | - |
Drexel University
| 5 years |
| Joe A. Lorusso | M | - |
Drexel University
| 2 years |
| Joseph F. Comero | M | - |
Drexel University
| 4 years |
| Woo-Keun Byeon | M | 64 |
Drexel University
| 2 years |
| Vincent Fandozzi | M | 59 |
Drexel University
| 4 years |
| Lance Roth | M | - |
Drexel University
| 4 years |
| Stephen Nickerson | M | - |
Drexel University
| 4 years |
| Dave Brown | M | - |
Drexel University
| 4 years |
| Bruce A. Chalmers | M | 57 |
Drexel University
| 4 years |
| Dan Birch | M | - |
Drexel University
| 4 years |
| Joseph A. Walicki | M | - |
Drexel University
| 5 years |
| Virginia Gallicchio | F | - |
Drexel University
| 5 years |
| Anil S Menawat | M | - |
Drexel University
| 4 years |
| Robert May | M | - |
Drexel University
| 5 years |
| Fred Buffone | M | - |
Drexel University
| 4 years |
| Bruce Culbert | M | - |
Drexel University
| 6 years |
| Konrad Kozik | M | - |
Drexel University
| 4 years |
| Charles E. deVoe | M | - |
Drexel University
| 4 years |
| Al Altomari | M | 65 |
Drexel University
| 4 years |
| Marc L. Rose | M | 59 |
Drexel University
| 4 years |
| Phil Garfinkle Garfinkle | M | 63 |
Drexel University
| 4 years |
| Kevin O'Hara | M | 63 |
Drexel University
| 4 years |
| Dan Morris | M | 70 |
Drexel University
| 1 years |
| Keith Creveling | M | - |
Drexel University
| 5 years |
| Gary F. McManus | M | - |
Drexel University
| 5 years |
| Alex J. Chanin | M | 55 |
Drexel University
| 4 years |
| Sue L. Schnaars | F | - |
Drexel University
| 5 years |
| Joseph Michael Warusz | M | 67 |
Drexel University
| 4 years |
| Julie H. Scribner | F | - |
Drexel University
| 4 years |
| Bob Moore | M | - |
Drexel University
| 3 years |
| William Pote | M | - |
Drexel University
| 4 years |
| Michael Hennigan | M | 64 |
Drexel University
| 4 years |
| James W. Preuninger | M | 64 |
Drexel University
| 4 years |
| Michael Baum | M | - |
Drexel University
| 5 years |
| Nancy G. Rogers | F | - |
Drexel University
| 5 years |
| Alex Katz | M | 64 |
Drexel University
| 5 years |
| John J. Brignola | M | - |
Drexel University
| 2 years |
| Scott K. Jones | M | - |
Drexel University
| 3 years |
| Jim Merriam | M | - |
Drexel University
| 2 years |
| Mike Edwards | M | 64 |
Drexel University
| 4 years |
| Nicholas Iacono | M | - |
Drexel University
| 4 years |
| Juan Marino | M | - |
Drexel University
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| Poland | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles Kunsch
- Personal Network
